Fol. Biol. 2020, 66, 123-132
https://doi.org/10.14712/fb2020066040123
Phenotype Variability in Czech Patients Carrying PAX6 Disease-Causing Variants
References
1. 2002) Killing the messenger: new insights into nonsense-mediated mRNA decay. J. Clin. Invest. 109, 3-6.
< , P. H. (https://doi.org/10.1172/JCI0214841>
2. 2009) Eye anomalies and neurological manifestations in patients with PAX6 mutations. Mol. Vis. 15, 2139-2145.
, Y. H., Huang, H. P., Hwu, W. L., Chien, Y. H., Chang, T. C., Lee, N. C. (
3. 2007) Three new PAX6 mutations including one causing an unusual ophthalmic phenotype associated with neurodevelopmental abnormalities. Mol. Vis. 13, 511-523.
, A., David, G., Schwartz, C., Jaliffa, C., Vieira, V., de la Houssaye, G., Bigot, K., Catin, F., Tattu, L., Chopin, C., Halimi, P., Roche, O., Van Regemorter, N., Munier, F., Schorderet, D., Dufier, J. L., Marsac, C., Ricquier, D., Menasche, M., Penfornis, A., Abitbol, M. (
4. 2018) Familial congenital cataract, coloboma, and nystagmus phenotype with variable expression caused by mutation in PAX6 in a South African family. Mol. Vis. 24, 407-413.
, S., Carstens, N., Ross, M., Bentley, D., Lopes, M., Peden, J., Kingsbury, Z., Tsogka, E., Barlow, R., Carmichael, T. R., Ramsay, M., Williams, S. E. (
5. 2007) A de novo nonsense mutation of PAX6 gene in a patient with aniridia, ataxia, and mental retardation. Am. J. Med. Genet. A 143A, 1802-1805.
< , C., D’Elia, A. V., Mazzanti, L., Moscano, F., Guidelli Guidi, S., Scarano, E., Turchetti, D., Franzoni, E., Romeo, G., Damante, G., Seri, M. (https://doi.org/10.1002/ajmg.a.31808>
6. 1995) The role of Pax-6 in eye and nasal development. Development 121, 1433-1442.
< , J. C., Davidson, D. R., Hill, R. E. (https://doi.org/10.1242/dev.121.5.1433>
7. 1999) Mutational analysis of PAX6: 16 novel mutations including 5 missense mutations with a mild aniridia phenotype. Eur. J. Hum. Genet. 7, 274-286.
< , K., Rosenberg, T., Sand, A., Brondum-Nielsen, K. (https://doi.org/10.1038/sj.ejhg.5200308>
8. 2001) Population-based risk estimates of Wilms tumour in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia. Hum. Genet. 109, 11-18.
< , K., Olsen, J. H., Sand, A., Pedersen, W., Carlsen, N., Bak Jylling, A. M., Lyngbye, T., Brondum-Nielsen, K., Rosenberg, T. (https://doi.org/10.1007/s004390100529>
9. 1993) PAX6 mutations in aniridia. Hum. Mol. Genet. 2, 915-920.
< , I. M., Seawright, A., Hardman, K., Hodgson, S., Zaletayev, D., Fekete, G., van Heyningen, V. (https://doi.org/10.1093/hmg/2.7.915>
10. 1995) Pax6: more than meets the eye. Trends Genet. 11, 268-272.
< , I., Van Heyningen, V. (https://doi.org/10.1016/S0168-9525(00)89073-3>
11. 2007) PAX6 mutations may be associated with high myopia. Ophthalmic Genet. 28, 179-182.
< , A. W., Kearns, L. S., Jamieson, R. V., Williamson, K. A., van Heyningen, V., Mackey, D. A. (https://doi.org/10.1080/13816810701356676>
12. 2009) Detailed ophthalmologic evaluation of 43 individuals with PAX6 mutations. Invest. Ophthalmol. Vis. Sci. 50, 2581-2590.
< , M., Williamson, K. A., Moore, A. T., van Heyningen, V. (https://doi.org/10.1167/iovs.08-2827>
13. 2012) A recurrent PAX6 mutation is associated with aniridia and congenital progressive cataract in a Chinese family. Mol. Vis. 18, 465-470.
, C., Wang, Q., Li, J., Zhu, Y., Shentu, X., Yao, K. (
14. 1992) The human PAX6 gene is mutated in two patients with aniridia. Nat. Genet. 1, 328-332.
< , T., Hanson, I., Zaletayev, D., Hodgson, S., Prosser, J., Seawright, A., Hastie, N., van Heyningen, V. (https://doi.org/10.1038/ng0892-328>
15. 2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581, 434-443.
< , K. J., Francioli, L. C., Tiao, G., Cummings, B. B., Alfoldi, J., Wang, Q., Collins, R. L., Laricchia, K. M., Ganna, A., Birnbaum, D. P., Gauthier, L. D., Brand, H., Solomonson, M., Watts, N. A., Rhodes, D., Singer-Berk, M., England, E. M., Seaby, E. G., Kosmicki, J. A., Walters, R. K., Tashman, K., Farjoun, Y., Banks, E., Poterba, T., Wang, A., Seed, C., Whiffin, N., Chong, J. X., Samocha, K. E., Pierce-Hoffman, E., Zappala, Z., O’Donnell-Luria, A. H., Minikel, E. V., Weisburd, B., Lek, M., Ware, J. S., Vittal, C., Armean, I. M., Bergelson, L., Cibulskis, K., Connolly, K. M., Covarrubias, M., Donnelly, S., Ferriera, S., Gabriel, S., Gentry, J., Gupta, N., Jeandet, T., Kaplan, D., Llanwarne, C., Munshi, R., Novod, S., Petrillo, N., Roazen, D., Ruano-Rubio, V., Saltzman, A., Schleicher, M., Soto, J., Tibbetts, K., Tolonen, C., Wade, G., Talkowski, M. E., Genome Aggregation Database, C., Neale, B. M., Daly, M. J., MacArthur, D. G. (https://doi.org/10.1038/s41586-020-2308-7>
16. 2016) An openly available online tool for implementing the ACMG/AMP standards and guidelines for the interpretation of sequence variants. Genet. Med. 18, 1165.
< , J., Maloney, K. A., Pollin, T. I., Jeng, L. J. (https://doi.org/10.1038/gim.2016.13>
17. 2007) A cell type-restricted mRNA surveillance pathway triggered by ribosome extension into the 3’ untranslated region. Nat. Struct. Mol. Biol. 14, 670-676.
< , J., Liebhaber, S. A. (https://doi.org/10.1038/nsmb1256>
18. 2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760.
< , H., Durbin, R. (https://doi.org/10.1093/bioinformatics/btp324>
19. 2012) Comparison between aniridia with and without PAX6 mutations: clinical and molecular analysis in 14 Korean patients with aniridia. Ophthalmology 119, 1258-1264.
< , H. T., Seo, E. J., Kim, G. H., Ahn, H., Lee, H. J., Shin, K. H., Lee, J. K., Yoo, H. W. (https://doi.org/10.1016/j.ophtha.2011.12.010>
20. 2017) PAX6 aniridia syndrome: clinics, genetics, and therapeutics. Curr. Opin. Ophthalmol. 28, 436-447.
< , H. T., Kim, D. H., Kim, H. (https://doi.org/10.1097/ICU.0000000000000405>
21. 2001) PAX6 mutation in a family with aniridia, congenital ptosis, and mental retardation. Clin. Genet. 60, 151-154.
< , A., Mari, F., Palmeri, S., Gambelli, S., Berti, G., Bruttini, M., Bardelli, A. M., Williamson, K., van Heyningen, V., Renieri, A. (https://doi.org/10.1034/j.1399-0004.2001.600210.x>
22. 2003) Keratopathy in congenital aniridia. Ocul. Surf. 1, 74-79.
< , K. L., Nordlund, M. L., Schwartz, G. S., Holland, E. J. (https://doi.org/10.1016/S1542-0124(12)70130-1>
23. 2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res, 20, 1297-1303.
< , A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., DePristo, M. A. (https://doi.org/10.1101/gr.107524.110>
24. 1964) Association of Wilms’s tumor with aniridia, hemihypertrophy and other congenital malformations. N. Engl. J. Med. 270, 922-927.
< , R. W., Fraumeni, J. F., Jr., Manning, M. D. (https://doi.org/10.1056/NEJM196404302701802>
25. 2012) Association of paired box 6 with high myopia in Japanese. Mol. Vis. 18, 2726-2735.
, M., Yamashiro, K., Nakanishi, H., Nakata, I., Akagi- Kurashige, Y., Tsujikawa, A., Moriyama, M., Ohno-Matsui, K., Mochizuki, M., Yamada, R., Matsuda, F., Yoshimura, N. (
26. 2018) Iris reconstruction using artificial iris prosthesis for management of aniridia. Eur. J. Ophthalmol. 28, 103-107.
< , Y. S., Osman, A. A., Hassanein, D. H., Zeid, A. M., Sherif, A. M. (https://doi.org/10.5301/ejo.5000991>
27. 2011) Ocular and systemic findings in a survey of aniridia subjects. J. AAPOS 15, 562-566.
< , P. A., Scott, M. L., Boyle, J. W. 4th, Lauderdale, J. D. (https://doi.org/10.1016/j.jaapos.2011.07.009>
28. 2017) PAX6 allelic heterogeneity in Mexican congenital aniridia patients: expanding the mutational spectrum with seven novel pathogenic variants. Clin. Exp. Ophthalmol. 45, 875-883.
< , S., Chacon-Camacho, O. F., Astiazaran, M. C., Ledesma-Gil, G., Zenteno, J. C. (https://doi.org/10.1111/ceo.12982>
29. 2013) PAX6 mutation in association with ptosis, cataract, iris hypoplasia, corneal opacification and diabetes: a new variant of familial aniridia? Clin. Exp. Ophthalmol. 41, 835-841.
< , N. M., Leyland, M., Mudhar, H. S., Lowndes, J., Owen, K. R., Stewart, H. (https://doi.org/10.1111/ceo.12109>
30. 2004) Paired-type homeodomain transcription factors are imported into the nucleus by karyopherin 13. Mol. Cell. Biol. 24, 4824-4834.
< , J. E., Shamsher, M. K., Radu, A. (https://doi.org/10.1128/MCB.24.11.4824-4834.2004>
31. 1998) PAX6 mutations reviewed. Hum. Mutat. 11, 93-108.
< , J., van Heyningen, V. (https://doi.org/10.1002/(SICI)1098-1004(1998)11:2<93::AID-HUMU1>3.0.CO;2-M>
32. 2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405-424.
< , S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., Voelkerding, K., Rehm, H. L., ACMG Laboratory Quality Assurance Committee (https://doi.org/10.1038/gim.2015.30>
33. 2008) Genetic analysis of chromosome 11p13 and the PAX6 gene in a series of 125 cases referred with aniridia. Am. J. Med. Genet. A 146A, 558-569.
< , D. O., Howarth, R. J., Williamson, K. A., van Heyningen, V., Beal, S. J., Crolla, J. A. (https://doi.org/10.1002/ajmg.a.32209>
34. 2016) Congenital aniridia: etiology, manifestations and management. Expert Rev. Ophthalmol. 11, 135-144.
< , M., Chauhan, B. K., Lathrop, K. L., Nischal, K. K. (https://doi.org/10.1586/17469899.2016.1152182>
35. 1991) Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region. Cell 67, 1059-1074.
< , C. C., Hirvonen, H., Miwa, H., Weil, M. M., Monaghan, P., Jordan, T., van Heyningen, V., Hastie, N. D., Meijers-Heijboer, H., Drechsler, M., Royer-Pokora, B., Collins, F., Swaroop, A., Strong, L. C., Saunders, G. F. (https://doi.org/10.1016/0092-8674(91)90284-6>
36. 2004) Ocular and nonocular findings in patients with aniridia. Can. J. Ophthalmol. 39, 632-638.
< , A., Cline, R. A. (https://doi.org/10.1016/S0008-4182(04)80028-0>
37. Nucleic Acids Res. 38, e164.
< , K., Li, M., Hakonarson, H. (2010) ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. https://doi.org/10.1093/nar/gkq603>
38. 2012) PAX6 mutations identified in 4 of 35 families with microcornea. Invest. Ophthalmol. Vis. Sci. 53, 6338-6342.
< , P., Sun, W., Li, S., Xiao, X., Guo, X., Zhang, Q. (https://doi.org/10.1167/iovs.12-10472>
39. 2020) Recurrent heterozygous PAX6 missense variants cause severe bilateral microphthalmia via predictable effects on DNA-protein interaction. Genet. Med. 22, 598-609.
< , K. A., Hall, H. N., Owen, L. J., Livesey, B. J., Hanson, I. M., Adams, G. G. W., Bodek, S., Calvas, P., Castle, B., Clarke, M., Deng, A. T., Edery, P., Fisher, R., Gillessen-Kaesbach, G., Heon, E., Hurst, J., Josifova, D., Lorenz, B., McKee, S., Meire, F., Moore, A. T., Parker, M., Reiff, C. M., Self, J., Tobias, E. S., Verheij, J., Willems, M., Williams, D., van Heyningen, V., Marsh, J. A., FitzPatrick, D. R. (https://doi.org/10.1038/s41436-019-0685-9>
40. 2016) Transcriptional and epigenetic mechanisms of early cortical development: An examination of how Pax6 coordinates cortical development. J. Comp. Neurol. 524, 609-629.
< , A. R., Rubenstein, J. L. (https://doi.org/10.1002/cne.23866>